2 Stocks I’ll Be Adding to My TFSA – Even With the TSX at All-Time Highs
As reasonably valued TFSA stocks today, Bank of Nova Scotia and Canadian National Railway offer reliable dividends and ...
Arcutis Biotherapeutics: +200% On ZORYVE Approval, But When Is The Next Leg Up?
Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.
Vuzix (VUZI) Q3 2024 Earnings Call Transcript
Greetings and welcome to the Vuzix third quarter for the period ending September 30th, 2024 financial results and business ...